Company Profile
CytoSorbents Stock Price, News & Catalysts
- Ticker:
- CTSO
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.31 USD (-12.61%)
Close
Last updated: August 20, 2026
30.1M USD
Market cap
Why the stock is moving
As of Aug 20, 2026, CTSO closed down 12.6% at $0.3111. No new same-company headline was identified in the current news window.
Company overview
Business overview
CytoSorbents is a medical technology company focused on blood purification and extracorporeal filtration systems. Its business is centered on critical-care and device-based purification rather than biotech development.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, CytoSorbents sits in medical devices and critical-care technology.
Business Model Characteristics
The company depends on clinical adoption, hospital procurement, and the expansion of its blood-purification platform.
Position Within the Biotechnology Landscape
CytoSorbents is a niche medtech name whose valuation is tied to adoption and clinical utility.
Future catalysts
- CytoSorbents’ catalysts are CytoSorb adoption, international reimbursement, and any update that shows hospital usage is stabilizing. The company needs to keep proving that the therapy can become a recurring part of critical-care workflow.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of CytoSorbents (CTSO)?
CytoSorbents (CTSO) most recently closed at 0.31 USD, a -12.61% move versus the previous session.
What is the market cap of CytoSorbents (CTSO)?
CytoSorbents currently has a market capitalization of 30.1M USD on BioPharmSignal.
What does CytoSorbents do?
CytoSorbents is a medical technology company focused on blood purification and extracorporeal filtration systems. Its business is centered on critical-care and device-based purification rather than biotech development.
On which exchange is CTSO stock listed?
CytoSorbents (CTSO) is associated with NASDAQ, United States, Biopharma.
What is CytoSorbents?
CytoSorbents’ catalysts are CytoSorb adoption, international reimbursement, and any update that shows hospital usage is stabilizing.
Which conditions is CytoSorbents targeting with CytoSorbents?
CytoSorbents’ catalysts are CytoSorb adoption, international reimbursement, and any update that shows hospital usage is stabilizing.
How does CytoSorbents describe recent progress with CytoSorbents?
CytoSorbents’ catalysts are CytoSorb adoption, international reimbursement, and any update that shows hospital usage is stabilizing.
What is CytoSorb?
CytoSorbents is a medical technology company focused on blood purification and extracorporeal filtration systems.